Jager, Eva <br/><br/>
Targeted drug delivery by gemtuzumab ozogamicin: mechanism-based mathematical model for treatment strategy improvement and therapy individualization.  [electronic resource] 

 -  PloS one  2011 
 - e24265 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0024265  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoglycosides--pharmacokinetics<br/>Antibodies, Monoclonal, Humanized--pharmacokinetics<br/>Antigens, CD--metabolism<br/>Antigens, Differentiation, Myelomonocytic--metabolism<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Gemtuzumab<br/>Humans<br/>Leukemia, Myeloid, Acute--metabolism<br/>Models, Theoretical<br/>Sialic Acid Binding Ig-like Lectin 3